Overview
Conscious Sedation for Cataract Operations Under Topical Anaesthesia
Status:
Completed
Completed
Trial end date:
2021-01-01
2021-01-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
Topical anaesthesia of the eye for ophthalmologic procedures avoids pain and discomfort of local anaesthetic injection in the peribulbar or retrobulbar block so that patient comfortability is achieved. Sedation during topical anaesthesia of the eye is mostly required to achieve anxiolysis, amnesia and keeping the patient calm all through the procedure. In the present study, the investigators will investigate the effect of nalbuphine/dexmedetomidine versus nalbuphine/propofol on the sedation as a primary outcome, intra-operative, postoperative analgesia, vital signs, patient and surgeon satisfaction and side effects as secondary outcomesPhase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Menoufia UniversityTreatments:
Anesthetics
Benoxinate
Dexmedetomidine
Nalbuphine
Ophthalmic Solutions
Procaine
Propofol
Criteria
Inclusion Criteria:- Both genders,
- 20 and 65 years,
- American Society of Anesthesiologists (ASA) physical status I and II,
- Scheduled for cataract extraction surgery under topical anaesthesia.
Exclusion Criteria:
- Known allergy to local anaesthetics,
- Allergy to study drugs,
- Second or third-degree heart block,
- Alcohol or drug abuse
- Morbid obesity, pregnant and lactating females,
- Patients with severe cardiac, renal and hepatic disorders.